Remove Generic Pharmaceutical Remove Insulin Remove Licensing Remove Packaging
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. It is a dipeptidyl peptidase-4 inhibitor that keeps insulin levels stable and reduces the amount of glucose produced by the body. a month for either 150 mg or 300 mg dose strength packages, and $3,462.13 billion ($8.72

Sales 98